Nolvadex or Tamoxifen for Breast Cancer

Tamoxifen (Nolvadex) is one of the most commonly prescribed drugs used to prevent breast cancer, either as an initial diagnosis or a recurrence (return). Tamoxifen is a hormone therapy and is known as a SERM (short for selective estrogen-receptor modulator). SERMS, which also include raloxifene (Evista) and Fareston (toremifene) work by blocking estrogen from attaching itself to the special hormone receptors on cancer cells.

Start Here:

A Survivor's Guide to Tamoxifen (Nolvadex)
Confused about who should take tamoxifen and what it's for? Start with PJ Hamel's FAQ on the popular hormone therapy.

Drug Resources - Patient Handouts

Tamoxifen
Tamoxifen has multiple uses, including treating metastatic breast cancer and reducing the chances of breast cancer in high-risk patients. Learn more about tamoxifen (Nolvadex).
Nolvadex
Nolvadex is the same as tamoxifen and is used in several ways, including treating breast cancer in certain patients after surgery and radiation therapy. Learn more about Nolvadex.

On Tamoxifen - A Doctor's Request:

Don't Stop Taking Your Meds
About a third of cancer patients stop taking their tamoxifen before they finish a 5-year course. This worries Dr. Kevin Knopf. Find out why.

Side Effects of Tamoxifen

Precautions and When to Talk to Your Doctor
Tamoxifen has rarely caused very serious (possibly fatal) strokes, blood clots in the lungs/legs, and cancer of the uterus.

The Big Picture:

Tamoxifen as a Hormone Therapy

Hormone therapy works by blocking estrogen that causes cell-proliferation. Tamoxifen (Nolvadex) has been the standard hormonal drug used for breast cancer.

Find out more >>

Bookmark

Save to My Home
Want to keep this page handy for later? Click Save to My Home and we'll add it to your My Home area.

Cancer Vixen's Take on Side Effects

Cartoon Blog - Sex Life After Tamoxifen

Discussing the side effects of tamoxifen takes guts. Uterine cancer is well-recognized as a risk, but sexual side effects are often approached in hushed tones -- or not at all.

Find out more >>